Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
- PMID: 8087844
- DOI: 10.1016/s0092-8674(94)90462-6
Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
Abstract
Reagents that inhibit the ubiquitin-proteasome proteolytic pathway in cells have not been available. Peptide aldehydes that inhibit major peptidase activities of the 20S and 26S proteasomes are shown to reduce the degradation of protein and ubiquitinated protein substrates by 26S particles. Unlike inhibitors of lysosomal proteolysis, these compounds inhibit the degradation of not only abnormal and short-lived polypeptides but also long-lived proteins in intact cells. We used these agents to test the importance of the proteasome in antigen presentation. When ovalbumin is introduced into the cytosol of lymphoblasts, these inhibitors block the presentation on MHC class I molecules of an ovalbumin-derived peptide by preventing its proteolytic generation. By preventing peptide production from cell proteins, these inhibitors block the assembly of class I molecules. Therefore, the proteasome catalyzes the degradation of the vast majority of cell proteins and generates most peptides presented on MHC class I molecules.
Similar articles
-
Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway.J Immunol. 1995 Aug 15;155(4):1767-75. J Immunol. 1995. PMID: 7636233
-
Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation.J Biol Chem. 1997 May 16;272(20):13437-45. doi: 10.1074/jbc.272.20.13437. J Biol Chem. 1997. PMID: 9148969
-
Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes.Nature. 1993 Sep 16;365(6443):264-7. doi: 10.1038/365264a0. Nature. 1993. PMID: 8396732
-
Role of proteasomes in antigen presentation.Enzyme Protein. 1993;47(4-6):354-69. doi: 10.1159/000468693. Enzyme Protein. 1993. PMID: 7697133 Review.
-
Proteolysis and class I major histocompatibility complex antigen presentation.Immunol Rev. 1999 Dec;172:49-66. doi: 10.1111/j.1600-065x.1999.tb01355.x. Immunol Rev. 1999. PMID: 10631936 Review.
Cited by
-
Genetic associations of T cell cancer immune response-related genes with T cell phenotypes and clinical outcomes of early-stage lung cancer.J Immunother Cancer. 2020 Aug;8(2):e000336. doi: 10.1136/jitc-2019-000336. J Immunother Cancer. 2020. PMID: 32764075 Free PMC article.
-
Proteasome inhibitor (MG132) rescues Nav1.5 protein content and the cardiac sodium current in dystrophin-deficient mdx (5cv) mice.Front Physiol. 2013 Mar 26;4:51. doi: 10.3389/fphys.2013.00051. eCollection 2013. Front Physiol. 2013. PMID: 23532763 Free PMC article.
-
Antigen processing and immune regulation in the response to tumours.Immunology. 2017 Jan;150(1):16-24. doi: 10.1111/imm.12675. Epub 2016 Oct 12. Immunology. 2017. PMID: 27658710 Free PMC article. Review.
-
Identification of Targets and Interaction Partners of Arginyl-tRNA Protein Transferase in the Moss Physcomitrella patens.Mol Cell Proteomics. 2016 Jun;15(6):1808-22. doi: 10.1074/mcp.M115.057190. Epub 2016 Apr 11. Mol Cell Proteomics. 2016. PMID: 27067052 Free PMC article.
-
The immunoproteasome and viral infection: a complex regulator of inflammation.Front Microbiol. 2015 Jan 29;6:21. doi: 10.3389/fmicb.2015.00021. eCollection 2015. Front Microbiol. 2015. PMID: 25688236 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials